menu
    • menu

    Company profile for Peak Bio

    NEW Drugs in Dev: 1
    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    Contact Supplier

    LEBSA- Your strategic API source for niche molecules.

    Virtual Booth

    Contact Supplier

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Our goal is to find innovative therapies that address significant unmet medical needs for patients with inflammatory, rare and specialty diseases, and cancer. Notice to recruiters All recruitment vendors (temporary staffing agencies, placement services, and professional recruiters) are prohibited from contacting our employees. In order to be an authorized vendor partner for Peak Bio, all such organizations must have a for...
    Our goal is to find innovative therapies that address significant unmet medical needs for patients with inflammatory, rare and specialty diseases, and cancer. Notice to recruiters All recruitment vendors (temporary staffing agencies, placement services, and professional recruiters) are prohibited from contacting our employees. In order to be an authorized vendor partner for Peak Bio, all such organizations must have a formal written agreement with Peak Bio’s Human Resources Department.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Peak BioUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    3350 W Bayshore Rd, Suite 100, Palo Alto, California 94303
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://peak-bio.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/peakbioinc/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Akari Completes Merger with Peak Bio Successfully
    Akari Completes Merger with Peak Bio Successfully

    14 Nov 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/11/14/2981638/0/en/Akari-Therapeutics-Announces-Successful-Completion-of-Merger-of-Akari-Therapeutics-and-Peak-Bio.html

    GLOBENEWSWIRE
    14 Nov 2024
    Share Share
    Akari Therapeutics Shareholder Approval for Peak Bio Merger
    Akari Therapeutics Shareholder Approval for Peak Bio Merger

    08 Nov 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/11/08/2977608/0/en/Akari-Therapeutics-Announces-Shareholder-Approval-in-Connection-With-Peak-Bio-Inc-Merger.html

    GLOBENEWSWIRE
    08 Nov 2024
    Share Share
    Akari Therapeutics Announces Effectiveness of Form S-4 and On Nov 7
    Akari Therapeutics Announces Effectiveness of Form S-4 and On Nov 7

    15 Oct 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/10/15/2963146/0/en/Akari-Therapeutics-Announces-Effectiveness-of-Form-S-4-and-General-Meeting-Date-of-November-7-2024-Related-to-Peak-Bio-Merger.html

    GLOBENEWSWIRE
    15 Oct 2024
    Share Share
    Akari Therapeutics Reports Q2 2024 Financial Results And Highlights
    Akari Therapeutics Reports Q2 2024 Financial Results And Highlights

    19 Aug 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/08/19/2932443/0/en/Akari-Therapeutics-Reports-Second-Quarter-2024-Financial-Results-and-Recent-Highlights.html

    GLOBENEWSWIRE
    19 Aug 2024
    Share Share
    Akari Therapeutics Reports Q1 2024 Financials, Highlights
    Akari Therapeutics Reports Q1 2024 Financials, Highlights

    16 May 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/05/16/2883321/0/en/Akari-Therapeutics-Reports-First-Quarter-2024-Financial-Results-and-Recent-Highlights.html

    GLOBENEWSWIRE
    16 May 2024
    Share Share
    Akari, Peak Bio Plan For Post-Merger Pipeline Prioritization
    Akari, Peak Bio Plan For Post-Merger Pipeline Prioritization

    01 May 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/05/01/2873218/0/en/Akari-Therapeutics-and-Peak-Bio-Announce-Portfolio-Prioritization-Plan-for-Combined-Go-Forward-Merger-Entity.html

    GLOBENEWSWIRE
    01 May 2024
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search